ACTRN12612001250820
Completed
Phase 2
Assessment and comparison of the pharmacokinetics of two doses of Androfeme using an open-label, phase 2, single centre, randomised, crossover study in healthy postmenopausal women
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- determination of blood testosterone levels using two doses of Androfem cream in postmenopausal women
- Sponsor
- Monash University
- Enrollment
- 8
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Healthy naturally postmenopausal women aged 50\-65 years
Exclusion Criteria
- •Allergy to almonds, major medical disorders or on recent hormonal treatment
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Assessment of pharmacokinetics and pharmacokinetic drug-drug interaction with ketoconazole of the metabolite S 41015 after single oral unlabelled microdoses of S 41015 and i.v. radiolabelled microdoses of [14C]-S 41015, and pharmacokinetics of S 38844 after single oral unlabelled microdose of S 38844 and i.v. radiolabelled microdose of [14C]-S 38844 in healthy male participantshart- en vaatziektencardiovascular diseasesNL-OMON38625Institut de Recherches Internationales Servier I.R.I.S6
Completed
Not Applicable
The evaluation of pharmacokinetic and pharmacodynamic properties of Propiverine Hydrochloride transdermal formulatiooveractive bladderJPRN-UMIN000011937Dept of Clinical Pharmacology and Therapeutics, Oita University Faculty of Medicine10
Completed
Phase 1
FarmaPEG-Ione. Healthy volunteers.Healthy VolunteersRPCEC00000039Center for Genetic Engineering and Biotechnology (CIGB)16
Completed
Not Applicable
A Pharmacokinetic and Pharmacodynamic Comparison of Prasugrel and Clopidogrel in Low Body Weight versus Higher Body Weight Aspirin-Treated Subjects with Stable Coronary Artery DiseaseCoronary Artery Diseaseillness of coronary arteries10011082NL-OMON34026Eli Lilly25
Active, not recruiting
Not Applicable
A Pharmacokinetic and Pharmacodynamic Comparison of Prasugrel (LY640315) versus Clopidogrel in Subjects with Stable Atherosclerosis - TABREUCTR2005-005292-15-SEEli Lilly and Company Ltd.110